Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotene Mouthwash is a commercially available, over-the-counter oral rinse primarily indicated for the symptomatic relief of dry mouth (xerostomia). It is formulated to mimic the natural protective environment of saliva through a combination of moisturizing agents and a salivary enzyme system, typically including lactoferrin, lysozyme, lactoperoxidase, and glucose oxidase. These enzymes are intended to supplement the mouth's natural defenses and maintain a healthy oral environment. In a clinical research context, the University of California, Los Angeles (UCLA) utilized Biotene as a placebo/control condition in a randomized crossover study (NCT03133299) evaluating the efficacy of an antibacterial mouthwash (Listerine) in preventing pharyngeal gonorrhea among high-risk populations. Biotene was selected as the comparator because it lacks the potent antibacterial essential oils found in antiseptic mouthwashes, serving as a non-antibacterial moisturizing rinse.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biotene Mouthwash.